Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)
Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the guideline in 2016 and revised in 2018. Over the past several years, many new evidences for the treatment of P...
Gespeichert in:
| Veröffentlicht in: | Liver cancer (Basel ) 2022-07, Vol.11 (4), p.315-328 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 328 |
|---|---|
| container_issue | 4 |
| container_start_page | 315 |
| container_title | Liver cancer (Basel ) |
| container_volume | 11 |
| creator | Sun, Juxian Guo, Rongping Bi, Xinyu Wu, Mengchao Tang, Zhaoyou Lau, Wan Yee Zheng, Shusen Wang, Xuehao Yu, Jinming Chen, Xiaoping Fan, Jia Dong, Jiahong Chen, Yongjun Cui, Yunfu Dai, Chaoliu Fang, Chihua Feng, Shuang Ji, Zhili Jia, Weidong Jia, Ningyang Li, Gong Li, Jing Li, Qiu Li, Jiangtao Liang, Tingbo Liu, Lianxin Lu, Shichun Lv, Yi Mao, Yilei Meng, Yan Meng, Zhiqiang Shen, Feng Shi, Jie Sun, Huichuan Tao, Kaishan Teng, Gaojun Wan, Xuying Wen, Tianfu Wu, Liqun Xia, Jinglin Ying, Mingang Zhai, Jian Zhang, Leida Zhang, Xuewen Zhang, Zhiwei Zhao, Haiping Zheng, Donghai Zhi, Xuting Zhou, Jie Zhou, Cuncai Zhou, Jian Zeng, Zhaochong Zhu, Kangshun Chen, Minshan Cai, Jianqiang Cheng, Shuqun |
| description | Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the guideline in 2016 and revised in 2018. Over the past several years, many new evidences for the treatment of PVTT become available, especially for the advent of new targeted drugs and immune checkpoint inhibitors which have further improved the prognosis of PVTT. So, the Chinese Association of Liver Cancer and Chinese Medical Doctor Association revised the 2018 version of the guideline to adapt to the development of PVTT treatment. Future treatment strategies for HCC with PVTT in China would depend on new evidences from more future clinical trials. |
| doi_str_mv | 10.1159/000523997 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_gale_infotracmisc_A726987706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A726987706</galeid><doaj_id>oai_doaj_org_article_901ff635b0164703893ca20527e85fde</doaj_id><sourcerecordid>A726987706</sourcerecordid><originalsourceid>FETCH-LOGICAL-c562t-964b500986cc151662e3cf800653861b1671e4f6ffe1c56f159e4c4143a44e143</originalsourceid><addsrcrecordid>eNptkk1vEzEQhlcIRKvSA3cOlri0hxTb64_1BakKpY0UCQ6Bq-V4x4nDrh3s3SL49TgkShVU-WBp_MxjzytX1VuCbwjh6gPGmNNaKfmiOidCsAnnvH5ZnVNa8wmRip9VlzlvCoYbjKWSr6uzmivZcCXOqz_3o2-h8wEycjGhT96sQsw-IxNatEhghh7CgKJDD7A1Q7TQdWNnEpqaZH2IvUG__LBGX2MaTIe-gw9oMfZFtVin2C_HjEpluvbBoCuKKUF3rR98DNdvqlfOdBkuD_tF9e3z3WL6MJl_uZ9Nb-cTywUdJkqwJcdYNcJawsuEFGrryiiC140gSyIkAeaEc0BKhyuZALOMsNowBmW7qGZ7bxvNRm-T7036raPx-l8hppU2afC2A60wcU7UfImJYBLXjaqtoSVfCQ13LRTXx71rOy57aG2JJpnuRHp6Evxar-KjVlQxxXARXB0EKf4cIQ-693mXqQkQx6xpuVU1rCG0oO__QzdxTKFEpanCuCYSE_VErUwZwAcXy712J9W3kgrVSIlFoW6eocpqofc2BnC-1E8arvcNNsWcE7jjjATr3b_Tx3_39IQfJq0gHcn5bLon9LZ1hXr3LHWQ_AV84Nmj</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2900317019</pqid></control><display><type>article</type><title>Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Karger Open Access</source><creator>Sun, Juxian ; Guo, Rongping ; Bi, Xinyu ; Wu, Mengchao ; Tang, Zhaoyou ; Lau, Wan Yee ; Zheng, Shusen ; Wang, Xuehao ; Yu, Jinming ; Chen, Xiaoping ; Fan, Jia ; Dong, Jiahong ; Chen, Yongjun ; Cui, Yunfu ; Dai, Chaoliu ; Fang, Chihua ; Feng, Shuang ; Ji, Zhili ; Jia, Weidong ; Jia, Ningyang ; Li, Gong ; Li, Jing ; Li, Qiu ; Li, Jiangtao ; Liang, Tingbo ; Liu, Lianxin ; Lu, Shichun ; Lv, Yi ; Mao, Yilei ; Meng, Yan ; Meng, Zhiqiang ; Shen, Feng ; Shi, Jie ; Sun, Huichuan ; Tao, Kaishan ; Teng, Gaojun ; Wan, Xuying ; Wen, Tianfu ; Wu, Liqun ; Xia, Jinglin ; Ying, Mingang ; Zhai, Jian ; Zhang, Leida ; Zhang, Xuewen ; Zhang, Zhiwei ; Zhao, Haiping ; Zheng, Donghai ; Zhi, Xuting ; Zhou, Jie ; Zhou, Cuncai ; Zhou, Jian ; Zeng, Zhaochong ; Zhu, Kangshun ; Chen, Minshan ; Cai, Jianqiang ; Cheng, Shuqun</creator><creatorcontrib>Sun, Juxian ; Guo, Rongping ; Bi, Xinyu ; Wu, Mengchao ; Tang, Zhaoyou ; Lau, Wan Yee ; Zheng, Shusen ; Wang, Xuehao ; Yu, Jinming ; Chen, Xiaoping ; Fan, Jia ; Dong, Jiahong ; Chen, Yongjun ; Cui, Yunfu ; Dai, Chaoliu ; Fang, Chihua ; Feng, Shuang ; Ji, Zhili ; Jia, Weidong ; Jia, Ningyang ; Li, Gong ; Li, Jing ; Li, Qiu ; Li, Jiangtao ; Liang, Tingbo ; Liu, Lianxin ; Lu, Shichun ; Lv, Yi ; Mao, Yilei ; Meng, Yan ; Meng, Zhiqiang ; Shen, Feng ; Shi, Jie ; Sun, Huichuan ; Tao, Kaishan ; Teng, Gaojun ; Wan, Xuying ; Wen, Tianfu ; Wu, Liqun ; Xia, Jinglin ; Ying, Mingang ; Zhai, Jian ; Zhang, Leida ; Zhang, Xuewen ; Zhang, Zhiwei ; Zhao, Haiping ; Zheng, Donghai ; Zhi, Xuting ; Zhou, Jie ; Zhou, Cuncai ; Zhou, Jian ; Zeng, Zhaochong ; Zhu, Kangshun ; Chen, Minshan ; Cai, Jianqiang ; Cheng, Shuqun ; On behalf of Chinese Association of Liver Cancer and Chinese Medical Doctor Association</creatorcontrib><description>Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the guideline in 2016 and revised in 2018. Over the past several years, many new evidences for the treatment of PVTT become available, especially for the advent of new targeted drugs and immune checkpoint inhibitors which have further improved the prognosis of PVTT. So, the Chinese Association of Liver Cancer and Chinese Medical Doctor Association revised the 2018 version of the guideline to adapt to the development of PVTT treatment. Future treatment strategies for HCC with PVTT in China would depend on new evidences from more future clinical trials.</description><identifier>ISSN: 2235-1795</identifier><identifier>EISSN: 1664-5553</identifier><identifier>DOI: 10.1159/000523997</identifier><identifier>PMID: 35978596</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Blood clot ; Blood clots ; Cancer therapies ; Care and treatment ; Classification ; Diagnosis ; guideline ; Guidelines ; Hepatectomy ; hepatocellular carcinoma ; Hepatoma ; Liver ; Liver cancer ; Medical diagnosis ; Medical prognosis ; Medical societies ; Metastasis ; multidisciplinary therapy ; Patients ; portal vein tumor thrombus ; Practice guidelines (Medicine) ; Prognosis ; Surgery ; Thrombosis ; Veins & arteries</subject><ispartof>Liver cancer (Basel ), 2022-07, Vol.11 (4), p.315-328</ispartof><rights>2022 The Author(s). Published by S. Karger AG, Basel</rights><rights>COPYRIGHT 2022 S. Karger AG</rights><rights>2022 The Author(s). Published by S. Karger AG, Basel . This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c562t-964b500986cc151662e3cf800653861b1671e4f6ffe1c56f159e4c4143a44e143</citedby><cites>FETCH-LOGICAL-c562t-964b500986cc151662e3cf800653861b1671e4f6ffe1c56f159e4c4143a44e143</cites><orcidid>0000-0001-5142-010X ; 0000-0002-3535-6467 ; 0000-0003-3278-0534 ; 0000-0003-3636-6664 ; 0000-0003-3593-6098 ; 0000-0002-6686-5440</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294940/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294940/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,27612,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Sun, Juxian</creatorcontrib><creatorcontrib>Guo, Rongping</creatorcontrib><creatorcontrib>Bi, Xinyu</creatorcontrib><creatorcontrib>Wu, Mengchao</creatorcontrib><creatorcontrib>Tang, Zhaoyou</creatorcontrib><creatorcontrib>Lau, Wan Yee</creatorcontrib><creatorcontrib>Zheng, Shusen</creatorcontrib><creatorcontrib>Wang, Xuehao</creatorcontrib><creatorcontrib>Yu, Jinming</creatorcontrib><creatorcontrib>Chen, Xiaoping</creatorcontrib><creatorcontrib>Fan, Jia</creatorcontrib><creatorcontrib>Dong, Jiahong</creatorcontrib><creatorcontrib>Chen, Yongjun</creatorcontrib><creatorcontrib>Cui, Yunfu</creatorcontrib><creatorcontrib>Dai, Chaoliu</creatorcontrib><creatorcontrib>Fang, Chihua</creatorcontrib><creatorcontrib>Feng, Shuang</creatorcontrib><creatorcontrib>Ji, Zhili</creatorcontrib><creatorcontrib>Jia, Weidong</creatorcontrib><creatorcontrib>Jia, Ningyang</creatorcontrib><creatorcontrib>Li, Gong</creatorcontrib><creatorcontrib>Li, Jing</creatorcontrib><creatorcontrib>Li, Qiu</creatorcontrib><creatorcontrib>Li, Jiangtao</creatorcontrib><creatorcontrib>Liang, Tingbo</creatorcontrib><creatorcontrib>Liu, Lianxin</creatorcontrib><creatorcontrib>Lu, Shichun</creatorcontrib><creatorcontrib>Lv, Yi</creatorcontrib><creatorcontrib>Mao, Yilei</creatorcontrib><creatorcontrib>Meng, Yan</creatorcontrib><creatorcontrib>Meng, Zhiqiang</creatorcontrib><creatorcontrib>Shen, Feng</creatorcontrib><creatorcontrib>Shi, Jie</creatorcontrib><creatorcontrib>Sun, Huichuan</creatorcontrib><creatorcontrib>Tao, Kaishan</creatorcontrib><creatorcontrib>Teng, Gaojun</creatorcontrib><creatorcontrib>Wan, Xuying</creatorcontrib><creatorcontrib>Wen, Tianfu</creatorcontrib><creatorcontrib>Wu, Liqun</creatorcontrib><creatorcontrib>Xia, Jinglin</creatorcontrib><creatorcontrib>Ying, Mingang</creatorcontrib><creatorcontrib>Zhai, Jian</creatorcontrib><creatorcontrib>Zhang, Leida</creatorcontrib><creatorcontrib>Zhang, Xuewen</creatorcontrib><creatorcontrib>Zhang, Zhiwei</creatorcontrib><creatorcontrib>Zhao, Haiping</creatorcontrib><creatorcontrib>Zheng, Donghai</creatorcontrib><creatorcontrib>Zhi, Xuting</creatorcontrib><creatorcontrib>Zhou, Jie</creatorcontrib><creatorcontrib>Zhou, Cuncai</creatorcontrib><creatorcontrib>Zhou, Jian</creatorcontrib><creatorcontrib>Zeng, Zhaochong</creatorcontrib><creatorcontrib>Zhu, Kangshun</creatorcontrib><creatorcontrib>Chen, Minshan</creatorcontrib><creatorcontrib>Cai, Jianqiang</creatorcontrib><creatorcontrib>Cheng, Shuqun</creatorcontrib><creatorcontrib>On behalf of Chinese Association of Liver Cancer and Chinese Medical Doctor Association</creatorcontrib><title>Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)</title><title>Liver cancer (Basel )</title><addtitle>Liver Cancer</addtitle><description>Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the guideline in 2016 and revised in 2018. Over the past several years, many new evidences for the treatment of PVTT become available, especially for the advent of new targeted drugs and immune checkpoint inhibitors which have further improved the prognosis of PVTT. So, the Chinese Association of Liver Cancer and Chinese Medical Doctor Association revised the 2018 version of the guideline to adapt to the development of PVTT treatment. Future treatment strategies for HCC with PVTT in China would depend on new evidences from more future clinical trials.</description><subject>Blood clot</subject><subject>Blood clots</subject><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Classification</subject><subject>Diagnosis</subject><subject>guideline</subject><subject>Guidelines</subject><subject>Hepatectomy</subject><subject>hepatocellular carcinoma</subject><subject>Hepatoma</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Medical diagnosis</subject><subject>Medical prognosis</subject><subject>Medical societies</subject><subject>Metastasis</subject><subject>multidisciplinary therapy</subject><subject>Patients</subject><subject>portal vein tumor thrombus</subject><subject>Practice guidelines (Medicine)</subject><subject>Prognosis</subject><subject>Surgery</subject><subject>Thrombosis</subject><subject>Veins & arteries</subject><issn>2235-1795</issn><issn>1664-5553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1vEzEQhlcIRKvSA3cOlri0hxTb64_1BakKpY0UCQ6Bq-V4x4nDrh3s3SL49TgkShVU-WBp_MxjzytX1VuCbwjh6gPGmNNaKfmiOidCsAnnvH5ZnVNa8wmRip9VlzlvCoYbjKWSr6uzmivZcCXOqz_3o2-h8wEycjGhT96sQsw-IxNatEhghh7CgKJDD7A1Q7TQdWNnEpqaZH2IvUG__LBGX2MaTIe-gw9oMfZFtVin2C_HjEpluvbBoCuKKUF3rR98DNdvqlfOdBkuD_tF9e3z3WL6MJl_uZ9Nb-cTywUdJkqwJcdYNcJawsuEFGrryiiC140gSyIkAeaEc0BKhyuZALOMsNowBmW7qGZ7bxvNRm-T7036raPx-l8hppU2afC2A60wcU7UfImJYBLXjaqtoSVfCQ13LRTXx71rOy57aG2JJpnuRHp6Evxar-KjVlQxxXARXB0EKf4cIQ-693mXqQkQx6xpuVU1rCG0oO__QzdxTKFEpanCuCYSE_VErUwZwAcXy712J9W3kgrVSIlFoW6eocpqofc2BnC-1E8arvcNNsWcE7jjjATr3b_Tx3_39IQfJq0gHcn5bLon9LZ1hXr3LHWQ_AV84Nmj</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Sun, Juxian</creator><creator>Guo, Rongping</creator><creator>Bi, Xinyu</creator><creator>Wu, Mengchao</creator><creator>Tang, Zhaoyou</creator><creator>Lau, Wan Yee</creator><creator>Zheng, Shusen</creator><creator>Wang, Xuehao</creator><creator>Yu, Jinming</creator><creator>Chen, Xiaoping</creator><creator>Fan, Jia</creator><creator>Dong, Jiahong</creator><creator>Chen, Yongjun</creator><creator>Cui, Yunfu</creator><creator>Dai, Chaoliu</creator><creator>Fang, Chihua</creator><creator>Feng, Shuang</creator><creator>Ji, Zhili</creator><creator>Jia, Weidong</creator><creator>Jia, Ningyang</creator><creator>Li, Gong</creator><creator>Li, Jing</creator><creator>Li, Qiu</creator><creator>Li, Jiangtao</creator><creator>Liang, Tingbo</creator><creator>Liu, Lianxin</creator><creator>Lu, Shichun</creator><creator>Lv, Yi</creator><creator>Mao, Yilei</creator><creator>Meng, Yan</creator><creator>Meng, Zhiqiang</creator><creator>Shen, Feng</creator><creator>Shi, Jie</creator><creator>Sun, Huichuan</creator><creator>Tao, Kaishan</creator><creator>Teng, Gaojun</creator><creator>Wan, Xuying</creator><creator>Wen, Tianfu</creator><creator>Wu, Liqun</creator><creator>Xia, Jinglin</creator><creator>Ying, Mingang</creator><creator>Zhai, Jian</creator><creator>Zhang, Leida</creator><creator>Zhang, Xuewen</creator><creator>Zhang, Zhiwei</creator><creator>Zhao, Haiping</creator><creator>Zheng, Donghai</creator><creator>Zhi, Xuting</creator><creator>Zhou, Jie</creator><creator>Zhou, Cuncai</creator><creator>Zhou, Jian</creator><creator>Zeng, Zhaochong</creator><creator>Zhu, Kangshun</creator><creator>Chen, Minshan</creator><creator>Cai, Jianqiang</creator><creator>Cheng, Shuqun</creator><general>S. Karger AG</general><general>Karger Publishers</general><scope>M--</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5142-010X</orcidid><orcidid>https://orcid.org/0000-0002-3535-6467</orcidid><orcidid>https://orcid.org/0000-0003-3278-0534</orcidid><orcidid>https://orcid.org/0000-0003-3636-6664</orcidid><orcidid>https://orcid.org/0000-0003-3593-6098</orcidid><orcidid>https://orcid.org/0000-0002-6686-5440</orcidid></search><sort><creationdate>20220701</creationdate><title>Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)</title><author>Sun, Juxian ; Guo, Rongping ; Bi, Xinyu ; Wu, Mengchao ; Tang, Zhaoyou ; Lau, Wan Yee ; Zheng, Shusen ; Wang, Xuehao ; Yu, Jinming ; Chen, Xiaoping ; Fan, Jia ; Dong, Jiahong ; Chen, Yongjun ; Cui, Yunfu ; Dai, Chaoliu ; Fang, Chihua ; Feng, Shuang ; Ji, Zhili ; Jia, Weidong ; Jia, Ningyang ; Li, Gong ; Li, Jing ; Li, Qiu ; Li, Jiangtao ; Liang, Tingbo ; Liu, Lianxin ; Lu, Shichun ; Lv, Yi ; Mao, Yilei ; Meng, Yan ; Meng, Zhiqiang ; Shen, Feng ; Shi, Jie ; Sun, Huichuan ; Tao, Kaishan ; Teng, Gaojun ; Wan, Xuying ; Wen, Tianfu ; Wu, Liqun ; Xia, Jinglin ; Ying, Mingang ; Zhai, Jian ; Zhang, Leida ; Zhang, Xuewen ; Zhang, Zhiwei ; Zhao, Haiping ; Zheng, Donghai ; Zhi, Xuting ; Zhou, Jie ; Zhou, Cuncai ; Zhou, Jian ; Zeng, Zhaochong ; Zhu, Kangshun ; Chen, Minshan ; Cai, Jianqiang ; Cheng, Shuqun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c562t-964b500986cc151662e3cf800653861b1671e4f6ffe1c56f159e4c4143a44e143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood clot</topic><topic>Blood clots</topic><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Classification</topic><topic>Diagnosis</topic><topic>guideline</topic><topic>Guidelines</topic><topic>Hepatectomy</topic><topic>hepatocellular carcinoma</topic><topic>Hepatoma</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Medical diagnosis</topic><topic>Medical prognosis</topic><topic>Medical societies</topic><topic>Metastasis</topic><topic>multidisciplinary therapy</topic><topic>Patients</topic><topic>portal vein tumor thrombus</topic><topic>Practice guidelines (Medicine)</topic><topic>Prognosis</topic><topic>Surgery</topic><topic>Thrombosis</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Juxian</creatorcontrib><creatorcontrib>Guo, Rongping</creatorcontrib><creatorcontrib>Bi, Xinyu</creatorcontrib><creatorcontrib>Wu, Mengchao</creatorcontrib><creatorcontrib>Tang, Zhaoyou</creatorcontrib><creatorcontrib>Lau, Wan Yee</creatorcontrib><creatorcontrib>Zheng, Shusen</creatorcontrib><creatorcontrib>Wang, Xuehao</creatorcontrib><creatorcontrib>Yu, Jinming</creatorcontrib><creatorcontrib>Chen, Xiaoping</creatorcontrib><creatorcontrib>Fan, Jia</creatorcontrib><creatorcontrib>Dong, Jiahong</creatorcontrib><creatorcontrib>Chen, Yongjun</creatorcontrib><creatorcontrib>Cui, Yunfu</creatorcontrib><creatorcontrib>Dai, Chaoliu</creatorcontrib><creatorcontrib>Fang, Chihua</creatorcontrib><creatorcontrib>Feng, Shuang</creatorcontrib><creatorcontrib>Ji, Zhili</creatorcontrib><creatorcontrib>Jia, Weidong</creatorcontrib><creatorcontrib>Jia, Ningyang</creatorcontrib><creatorcontrib>Li, Gong</creatorcontrib><creatorcontrib>Li, Jing</creatorcontrib><creatorcontrib>Li, Qiu</creatorcontrib><creatorcontrib>Li, Jiangtao</creatorcontrib><creatorcontrib>Liang, Tingbo</creatorcontrib><creatorcontrib>Liu, Lianxin</creatorcontrib><creatorcontrib>Lu, Shichun</creatorcontrib><creatorcontrib>Lv, Yi</creatorcontrib><creatorcontrib>Mao, Yilei</creatorcontrib><creatorcontrib>Meng, Yan</creatorcontrib><creatorcontrib>Meng, Zhiqiang</creatorcontrib><creatorcontrib>Shen, Feng</creatorcontrib><creatorcontrib>Shi, Jie</creatorcontrib><creatorcontrib>Sun, Huichuan</creatorcontrib><creatorcontrib>Tao, Kaishan</creatorcontrib><creatorcontrib>Teng, Gaojun</creatorcontrib><creatorcontrib>Wan, Xuying</creatorcontrib><creatorcontrib>Wen, Tianfu</creatorcontrib><creatorcontrib>Wu, Liqun</creatorcontrib><creatorcontrib>Xia, Jinglin</creatorcontrib><creatorcontrib>Ying, Mingang</creatorcontrib><creatorcontrib>Zhai, Jian</creatorcontrib><creatorcontrib>Zhang, Leida</creatorcontrib><creatorcontrib>Zhang, Xuewen</creatorcontrib><creatorcontrib>Zhang, Zhiwei</creatorcontrib><creatorcontrib>Zhao, Haiping</creatorcontrib><creatorcontrib>Zheng, Donghai</creatorcontrib><creatorcontrib>Zhi, Xuting</creatorcontrib><creatorcontrib>Zhou, Jie</creatorcontrib><creatorcontrib>Zhou, Cuncai</creatorcontrib><creatorcontrib>Zhou, Jian</creatorcontrib><creatorcontrib>Zeng, Zhaochong</creatorcontrib><creatorcontrib>Zhu, Kangshun</creatorcontrib><creatorcontrib>Chen, Minshan</creatorcontrib><creatorcontrib>Cai, Jianqiang</creatorcontrib><creatorcontrib>Cheng, Shuqun</creatorcontrib><creatorcontrib>On behalf of Chinese Association of Liver Cancer and Chinese Medical Doctor Association</creatorcontrib><collection>Karger Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Liver cancer (Basel )</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Juxian</au><au>Guo, Rongping</au><au>Bi, Xinyu</au><au>Wu, Mengchao</au><au>Tang, Zhaoyou</au><au>Lau, Wan Yee</au><au>Zheng, Shusen</au><au>Wang, Xuehao</au><au>Yu, Jinming</au><au>Chen, Xiaoping</au><au>Fan, Jia</au><au>Dong, Jiahong</au><au>Chen, Yongjun</au><au>Cui, Yunfu</au><au>Dai, Chaoliu</au><au>Fang, Chihua</au><au>Feng, Shuang</au><au>Ji, Zhili</au><au>Jia, Weidong</au><au>Jia, Ningyang</au><au>Li, Gong</au><au>Li, Jing</au><au>Li, Qiu</au><au>Li, Jiangtao</au><au>Liang, Tingbo</au><au>Liu, Lianxin</au><au>Lu, Shichun</au><au>Lv, Yi</au><au>Mao, Yilei</au><au>Meng, Yan</au><au>Meng, Zhiqiang</au><au>Shen, Feng</au><au>Shi, Jie</au><au>Sun, Huichuan</au><au>Tao, Kaishan</au><au>Teng, Gaojun</au><au>Wan, Xuying</au><au>Wen, Tianfu</au><au>Wu, Liqun</au><au>Xia, Jinglin</au><au>Ying, Mingang</au><au>Zhai, Jian</au><au>Zhang, Leida</au><au>Zhang, Xuewen</au><au>Zhang, Zhiwei</au><au>Zhao, Haiping</au><au>Zheng, Donghai</au><au>Zhi, Xuting</au><au>Zhou, Jie</au><au>Zhou, Cuncai</au><au>Zhou, Jian</au><au>Zeng, Zhaochong</au><au>Zhu, Kangshun</au><au>Chen, Minshan</au><au>Cai, Jianqiang</au><au>Cheng, Shuqun</au><aucorp>On behalf of Chinese Association of Liver Cancer and Chinese Medical Doctor Association</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)</atitle><jtitle>Liver cancer (Basel )</jtitle><addtitle>Liver Cancer</addtitle><date>2022-07-01</date><risdate>2022</risdate><volume>11</volume><issue>4</issue><spage>315</spage><epage>328</epage><pages>315-328</pages><issn>2235-1795</issn><eissn>1664-5553</eissn><abstract>Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the guideline in 2016 and revised in 2018. Over the past several years, many new evidences for the treatment of PVTT become available, especially for the advent of new targeted drugs and immune checkpoint inhibitors which have further improved the prognosis of PVTT. So, the Chinese Association of Liver Cancer and Chinese Medical Doctor Association revised the 2018 version of the guideline to adapt to the development of PVTT treatment. Future treatment strategies for HCC with PVTT in China would depend on new evidences from more future clinical trials.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>35978596</pmid><doi>10.1159/000523997</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0001-5142-010X</orcidid><orcidid>https://orcid.org/0000-0002-3535-6467</orcidid><orcidid>https://orcid.org/0000-0003-3278-0534</orcidid><orcidid>https://orcid.org/0000-0003-3636-6664</orcidid><orcidid>https://orcid.org/0000-0003-3593-6098</orcidid><orcidid>https://orcid.org/0000-0002-6686-5440</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2235-1795 |
| ispartof | Liver cancer (Basel ), 2022-07, Vol.11 (4), p.315-328 |
| issn | 2235-1795 1664-5553 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A726987706 |
| source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Karger Open Access |
| subjects | Blood clot Blood clots Cancer therapies Care and treatment Classification Diagnosis guideline Guidelines Hepatectomy hepatocellular carcinoma Hepatoma Liver Liver cancer Medical diagnosis Medical prognosis Medical societies Metastasis multidisciplinary therapy Patients portal vein tumor thrombus Practice guidelines (Medicine) Prognosis Surgery Thrombosis Veins & arteries |
| title | Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T21%3A34%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Guidelines%20for%20Diagnosis%20and%20Treatment%20of%20Hepatocellular%20Carcinoma%20with%20Portal%20Vein%20Tumor%20Thrombus%20in%20China%20(2021%20Edition)&rft.jtitle=Liver%20cancer%20(Basel%20)&rft.au=Sun,%20Juxian&rft.aucorp=On%20behalf%20of%20Chinese%20Association%20of%20Liver%20Cancer%20and%20Chinese%20Medical%20Doctor%20Association&rft.date=2022-07-01&rft.volume=11&rft.issue=4&rft.spage=315&rft.epage=328&rft.pages=315-328&rft.issn=2235-1795&rft.eissn=1664-5553&rft_id=info:doi/10.1159/000523997&rft_dat=%3Cgale_doaj_%3EA726987706%3C/gale_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2900317019&rft_id=info:pmid/35978596&rft_galeid=A726987706&rft_doaj_id=oai_doaj_org_article_901ff635b0164703893ca20527e85fde&rfr_iscdi=true |